Patent · US Expired

Method for determining sepsis using pro-ANF

US7498139B2 · kind B2 · utility

14Cited by

1References

4Claims

0Family size

Assignee

B.R.A.H.M.S GMBH · DE

Inventors

Andreas Bergmann · Berlin, DE
Joachim Struck · Berlin, DE
Wolfgang Weglöhner · Berlin, DE

Key dates

Filing date	Mar 25, 2004
Grant date	Mar 3, 2009
Priority date	—
Expiry date	Nov 22, 2024

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/585
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Uses of recombinant procalcitonin 3-116 in the diagnosis and therapy of septic diseases and the measurement of prohormones other than procalcitonin, and of dipeptidyl peptidase IV, as biomarkers in the diagnosis of sepsis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.